Urine test to detect cancer
This article was originally published in Start Up
UroSens Ltd. has developed a test that measures the presence of dividing cells in a urine sample, where there should be no dividing cells, and thus is indicative of cancer. The start-up's lead indication is bladder cancer, but it is exploring its use in other cancers, including prostate.
You may also be interested in...
Sandoz has closed its deal to acquire the Cimerli US ranibizumab biosimilar business from Coherus “ahead of anticipated timelines.”
Lilly’s CEO indicates that the long-standing IPR debate that has generally divided the developed and developing world is largely a “false narrative.” The executive also called for lowering regulatory barriers in India amid expectations of the potential debut of Zepbound/Mounjaro in the country next year.
A pioneering approval filing for a therapeutic app by Shionogi is set to herald expansion of ADHD therapies beyond the pill in Japan, along with growth in the pediatric segment for the disorder.